Cargando…

Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening

Monoclonal antibodies that target SARS-CoV-2 with high affinity are valuable for a wide range of biomedical applications involving novel coronavirus disease (COVID-19) diagnosis, treatment, and prophylactic intervention. Strategies for the rapid and reliable isolation of these antibodies, especially...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schardt, John S., Pornnoppadol, Ghasidit, Desai, Alec A., Park, Kyung Soo, Zupancic, Jennifer M., Makowski, Emily K., Smith, Matthew D., Chen, Hongwei, Garcia de Mattos Barbosa, Mayara, Cascalho, Marilia, Lanigan, Thomas M., Moon, James J., Tessier, Peter M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528929/ https://www.ncbi.nlm.nih.gov/pubmed/34671080 http://dx.doi.org/10.1038/s41598-021-99401-x

Ejemplares similares

Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis
por: Zupancic, Jennifer M., et al.
Publicado: (2021)

A hybridoma-derived monoclonal antibody with high homology to the aberrant myeloma light chain
por: Pornnoppadol, Ghasidit, et al.
Publicado: (2021)

38227 Specific and highly potent human monoclonal antibodies against SARS-CoV-2
por: de Mattos Barbosa, Mayara Garcia, et al.
Publicado: (2021)

Facile isolation of high-affinity nanobodies from synthetic libraries using CDR-swapping mutagenesis
por: Zupancic, Jennifer M., et al.
Publicado: (2022)

Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space
por: Makowski, Emily K., et al.
Publicado: (2022)

Mutational analysis of SARS-CoV-2 variants of concern reveals key tradeoffs between receptor affinity and antibody escape
por: Makowski, Emily K., et al.
Publicado: (2022)

IgV somatic mutation of human anti–SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity
por: de Mattos Barbosa, Mayara Garcia, et al.
Publicado: (2021)

Encapsulation of ovarian allograft precludes immune rejection and promotes restoration of endocrine function in immune-competent ovariectomized mice
por: Day, James Ronald, et al.
Publicado: (2019)

Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity
por: Desai, Alec A., et al.
Publicado: (2021)

Conformation-Dependent High-Affinity Potent Ricin-Neutralizing Monoclonal Antibodies
por: Hu, Wei-Gang, et al.
Publicado: (2013)

Highly sensitive detection of antibody nonspecific interactions using flow cytometry
por: Makowski, Emily K., et al.
Publicado: (2021)

Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralization
por: Noy-Porat, Tal, et al.
Publicado: (2023)

Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
por: Hurlburt, Nicholas K., et al.
Publicado: (2020)

Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
por: Hurlburt, Nicholas K., et al.
Publicado: (2020)

Reduction of therapeutic antibody self-association using yeast-display selections and machine learning
por: Makowski, Emily K., et al.
Publicado: (2022)

Potent Dengue Virus Neutralization by a Therapeutic Antibody with Low Monovalent Affinity Requires Bivalent Engagement
por: Edeling, Melissa A., et al.
Publicado: (2014)

Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods
por: Makowski, Emily K., et al.
Publicado: (2021)

An Affinity Propagation-Based DNA Motif Discovery Algorithm
por: Sun, Chunxiao, et al.
Publicado: (2015)

Discovery and Characterization of a Potent Interleukin-6 Binding Peptide with Neutralizing Activity In Vivo
por: Ranganath, Sheila, et al.
Publicado: (2015)

Binding affinity landscapes constrain the evolution of broadly neutralizing anti-influenza antibodies
por: Phillips, Angela M, et al.
Publicado: (2021)

TNFRSF13B polymorphisms counter microbial adaptation to enteric IgA
por: Platt, Jeffrey L., et al.
Publicado: (2021)

The rate of mutation of a single gene
por: Balin, Samuel J., et al.
Publicado: (2010)

IgM in the Kidney: A Multiple Personality Disorder
por: Platt, Jeffrey L., et al.
Publicado: (2015)

Cell Fusion in Malignancy: A Cause or Consequence? A Provocateur or Cure?
por: Platt, Jeffrey L., et al.
Publicado: (2019)

Challenges and potentials of xenotransplantation
por: Cascalho, Marilia, et al.
Publicado: (2008)

TNFRSF13B Diversification Fueled by B Cell Responses to Environmental Challenges—A Hypothesis
por: Cascalho, Marilia, et al.
Publicado: (2021)

TNFRSF13B in B cell responses to organ transplantation
por: Cascalho, Marilia, et al.
Publicado: (2023)

Encapsulated Allografts Preclude Host Sensitization and Promote Ovarian Endocrine Function in Ovariectomized Young Rhesus Monkeys and Sensitized Mice
por: Day, James R., et al.
Publicado: (2023)

Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods
por: Singh, Natesh, et al.
Publicado: (2018)

Durable targeting of B-lymphocytes in living mice
por: Cascalho, M., et al.
Publicado: (2018)

The discovery of neutral currents
por: Haidt, Dieter
Publicado: (2004)

TNFRSF13B genotypes control immune-mediated pathology by regulating the functions of innate B cells
por: de Mattos Barbosa, Mayara Garcia, et al.
Publicado: (2021)

Discovery and characterization of potent IL-21 neutralizing antibodies via a novel alternating antigen immunization and humanization strategy
por: Varkey, Reena, et al.
Publicado: (2019)

Antibody affinity versus dengue morphology influences neutralization
por: Fibriansah, Guntur, et al.
Publicado: (2021)

Regional delivery of immunosuppression for transplantation of vascularized composite allografts: opportunities near and far
por: Platt, Jeffrey L., et al.
Publicado: (2021)

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody
por: Valenzuela Nieto, Guillermo, et al.
Publicado: (2021)

Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies
por: Hanke, Leo, et al.
Publicado: (2022)

The Discovery of Weak Neutral Currents
por: Haidt, Dieter
Publicado: (2015)

The discovery of the weak neutral currents
Publicado: (2004)

Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection
por: Guo, Yu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nd1scf0a64qclj4devmc18ch2p